Suchergebnisse - "Abrams, Stephen L"

PubPharm (76)

1

Effects of chloroquine and hydroxychloroquine on the sensitivity of pancreatic cancer cells to targeted therapies

enthalten in: Advances in biological regulation | 2023

von McCubrey, J. | Abrams, S. | Follo, M. | +4

2

Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression

enthalten in: Cells | 2022

von McCubrey, J. | Yang, L. | Abrams, S. | +7

3

Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties

enthalten in: Aging | 2022

von McCubrey, J. | Meher, A. | Akula, S. | +10

4

Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53

enthalten in: Cells | 2022

von Abrams, S. | Duda, P. | Akula, S. | +11

5

APR-246-The Mutant TP53 Reactivator-Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer Cells

enthalten in: Biomolecules | 2022

von McCubrey, J. | Abrams, S. | Steelman, L. | +6

6

Effects of the MDM2 inhibitor Nutlin-3a on sensitivity of pancreatic cancer cells to berberine and modified berberines in the presence and absence of WT-TP53

enthalten in: Advances in biological regulation | 2022

von Abrams, S. | Akula, S. | Steelman, L. | +11

7

GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutraceuticals

enthalten in: Cells | 2021

von Abrams, S. | Akula, S. | Meher, A. | +14

8

Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53

enthalten in: Advances in biological regulation | 2021

von Abrams, S. | Akula, S. | Martelli, A. | +10

9

Therapeutic resistance in breast cancer cells can result from deregulated EGFR signaling

enthalten in: Advances in biological regulation | 2020

von Steelman, L. | Chappell, W. | Akula, S. | +10

10

GSK-3 and miRs : Master regulators of therapeutic sensitivity of cancer cells

enthalten in: Biochimica et biophysica acta. Molecular cell research | 2020

von Duda, P. | Akula, S. | Abrams, S. | +4

1
2
3
4
5
6
7
8
Nächster »
[8]